2021
DOI: 10.1002/joa3.12652
|View full text |Cite
|
Sign up to set email alerts
|

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

Abstract: The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in Asia‐Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The Practice Guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 202… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
43
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 57 publications
(55 citation statements)
references
References 331 publications
(533 reference statements)
1
43
0
Order By: Relevance
“…This is an executive summary of the 2021 focused update of the 2017 consensus guidelines of the Asia-Pacific Heart Rhythm Society (APHRS) on stroke prevention in AF. The full document has been published in Journal of Arrhythmia 6 and includes further details of the evidence/data pertaining to the recommendations made in these guidelines.…”
Section: Epidemiology Of Af and Risk Of Af-related Strokementioning
confidence: 99%
See 1 more Smart Citation
“…This is an executive summary of the 2021 focused update of the 2017 consensus guidelines of the Asia-Pacific Heart Rhythm Society (APHRS) on stroke prevention in AF. The full document has been published in Journal of Arrhythmia 6 and includes further details of the evidence/data pertaining to the recommendations made in these guidelines.…”
Section: Epidemiology Of Af and Risk Of Af-related Strokementioning
confidence: 99%
“… * This is an executive summary of the full consensus guideline, which is published in Journal of Arrhythmia by Chao et al 6 …”
mentioning
confidence: 99%
“…For very elderly patients with NVAF, lower dosages of NOACs were used or lower INR target of VKA was achieved (e.g., dabigatran 110 mg twice daily, rivaroxaban 15 mg once daily, edoxaban 30 mg once daily, apixaban 2.5 mg twice daily, warfarin INR target 1.6–2.6) [10] , [11] , [12] , [13] , [14] . Decisions to prescribe reduced dose NOACs or low INR target VKA are made based on the specific considerations on age, weight, renal function and use of specific concomitant medications.…”
Section: Resultsmentioning
confidence: 99%
“…Some previous studies [27] , [28] , [29] , [30] suggest that inappropriate dose reduction has been associated with a higher risk for embolism in patients with NVAF. Therefore, we conditionally adjusted the dosage of NOACs strictly following the recommendations from updated guidelines and consensus (age, glomerular filtration rate [eGFR], weight, history of bleeding or need to be combined with a strong P glycoprotein inhibitor or antiplatelet medicine) in whole study subjects [13] , [14] , [31] . The individual lower dosage of NOACs medication plans in our very elderly patients with NVAF included dabigatran 110 mg twice daily, rivaroxaban 15 mg once daily, edoxaban 30 mg once daily, apixaban 2.5 mg twice daily.…”
Section: Discussionmentioning
confidence: 99%
“…AF increases the risk of ischemic stroke and systemic embolism (IS/SE) ( 7 ), and oral anticoagulants (OACs) are recommended in high-risk patients unless contraindications exist ( 8 , 9 ). Because of comparable or better efficacy and better safety, non-vitamin K antagonist oral anticoagulants (NOACs) have replaced warfarin as the mainstream OAC for stroke prevention.…”
Section: Introductionmentioning
confidence: 99%